Addressing the Shortage of GLP-1 RA and Dual GIP/GLP-1 RA-Based Therapies—A Systematic Review

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonists (GIP/GLP-1 RAs) have transformed disease management, particularly in diabetes and obesity. However, recent shortages have disrupted patient...

Full description

Bibliographic Details
Published in:Diabetology
Main Authors: Velimir Altabas, Zrinka Orlović, Maja Baretić
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Subjects:
GLP-1 RA
dual GIP/GLP-1 RA
drug shortage
obesity management
diabetes management
pharmaceutical ethics
Online Access:https://www.mdpi.com/2673-4540/6/6/52

Internet

https://www.mdpi.com/2673-4540/6/6/52

Similar Items